Padang Ratnasari, Chandrashekar Nikhitha, Indrabhinduwat Manasawee, Scott Christopher G, Luis Sushil A, Chandrasekaran Krishnaswamy, Michelena Hector I, Nkomo Vuyisile T, Pislaru Sorin V, Pellikka Patricia A, Kane Garvan C
Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Eur Heart J. 2020 Mar 21;41(12):1273-1282. doi: 10.1093/eurheartj/ehaa037.
Right ventricular dysfunction (RVD) is an important determinant of functional status and survival in various diseases states. Data are sparse on the epidemiology and outcome of patients with severe RVD. This study examined the characteristics, aetiology, and survival of patients with severe RVD.
Retrospective study of consecutive patients with severe RVD diagnosed by transthoracic echocardiography (TTE) between 2011 and 2015 in a single tertiary referral institution. Patients with prior cardiac surgery, mechanical assist devices, and congenital heart disease were excluded. Primary endpoint was all-cause mortality. In 64 728 patients undergoing TTE, the prevalence of ≥mild RVD was 21%. This study focused on the cohort of 1299 (4%) patients with severe RVD; age 64 ± 16 years; 61% male. The most common causes of severe RVD were left-sided heart diseases (46%), pulmonary thromboembolic disease (18%), chronic lung disease/hypoxia (CLD; 17%), and pulmonary arterial hypertension (PAH; 11%). After 2 ± 2 years of follow-up, 701 deaths occurred, 66% within the first year of diagnosis. The overall probability of survival at 1- and 5 years for the entire cohort were 61% [95% confidence interval (CI) 58-64%] and 35% (95% CI 31-38%), respectively. In left-sided heart diseases, 1- and 5-year survival rates were 61% (95% CI 57-65%) and 33% (95% CI 28-37%), respectively; vs. 76% (95% CI 68-82%) and 50% (95% CI 40-59%) in PAH, vs. 71% (95% CI 64-76%) and 49% (95% CI 41-58%) in thromboembolic diseases, vs. 42% (95% CI 35-49%) and 8% (95% CI 4-15%) in CLD (log-rank P < 0.0001). Presence of ≥moderate tricuspid regurgitation portended worse survival in severe RVD.
One-year mortality of patients with severe RVD was high (∼40%) and dependent on the aetiology of RVD. Left-sided heart diseases is the most common cause of severe RVD but prognosis was worst in CLD.
右心室功能障碍(RVD)是多种疾病功能状态和生存的重要决定因素。关于严重RVD患者的流行病学和预后的数据稀少。本研究调查了严重RVD患者的特征、病因和生存率。
对2011年至2015年在一家三级转诊机构通过经胸超声心动图(TTE)诊断为严重RVD的连续患者进行回顾性研究。排除既往有心脏手术、机械辅助装置和先天性心脏病的患者。主要终点是全因死亡率。在64728例接受TTE检查的患者中,≥轻度RVD的患病率为21%。本研究聚焦于1299例(4%)严重RVD患者队列;年龄64±16岁;61%为男性。严重RVD最常见的病因是左心疾病(46%)、肺血栓栓塞性疾病(18%)、慢性肺病/缺氧(CLD;17%)和肺动脉高压(PAH;11%)。经过2±2年的随访,发生701例死亡,66%在诊断后的第一年内。整个队列1年和5年的总体生存率分别为61%[95%置信区间(CI)58 - 64%]和35%(95%CI 31 - 38%)。在左心疾病中,1年和5年生存率分别为61%(95%CI 57 - 65%)和33%(95%CI 28 - 37%);PAH患者分别为76%(95%CI 68 - 82%)和50%(95%CI 40 - 59%),血栓栓塞性疾病患者分别为71%(95%CI 64 - 76%)和49%(95%CI 41 - 58%),CLD患者分别为42%(95%CI 35 - 49%)和8%(95%CI 4 - 15%)(对数秩检验P<0.0001)。存在≥中度三尖瓣反流预示严重RVD患者的生存率更差。
严重RVD患者的1年死亡率很高(约40%),且取决于RVD的病因。左心疾病是严重RVD最常见的病因,但CLD患者的预后最差。